Edward Averbukh
Overview
Explore the profile of Edward Averbukh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erdinest N, Eshel Y, Saban O, Averbukh E, Khateb S, Lavy I
Eur J Ophthalmol
. 2025 Mar;
:11206721241310468.
PMID: 40080848
IntroductionThe current case series presents the triangular suture technique (TST) for managing intraocular lens (IOL) subluxation in pseudoexfoliation (PXF) syndrome patients, a condition increasing the risk of IOL dislocation post-cataract...
2.
Ross M, Sade K, Obolensky A, Averbukh E, Desrosiers M, Rosov A, et al.
Gene Ther
. 2024 Oct;
31(11-12):580-586.
PMID: 39472677
Gene augmentation therapy is a promising treatment for incurable, blinding inherited retinal diseases, and intravitreal delivery is being studied as a safe alternative to subretinal injections. Adeno-Associated Viruses (AAV) are...
3.
Averbukh E, Slushetz Y, Levy J, Patal R, Mandelbaum Y, Arieli Y
Ophthalmol Sci
. 2024 Jun;
4(5):100512.
PMID: 38881607
Purpose: To evaluate the divergence between the neodymium-doped yttrium aluminum garnet (Nd:YAG) surgical laser and the aiming diode laser beams foci. Design: Optical analysis and measurements were performed using a...
4.
Shmueli O, Nitzan I, Averbukh E
Case Rep Ophthalmol
. 2022 Nov;
13(3):793.
PMID: 36341040
This report describes a case of central serous chorioretinopathy (CSCR) occurring following cessation of terbinafine treatment. A 51-year-old man presented for a routine ophthalmic examination. He was treated with oral...
5.
Mckyton A, Averbukh E, Marks Ohana D, Levin N, Banin E
J Neurosci
. 2021 Aug;
41(35):7363-7371.
PMID: 34349002
The ability of the adult human brain to develop function following correction of congenital deafferentation is controversial. Specifically, cases of recovery from congenital visual deficits are rare. -achromatopsia is a...
6.
Corredores J, Hemo I, Jaouni T, Habot-Wilner Z, Kramer M, Shulman S, et al.
Int J Ophthalmol
. 2021 Jan;
14(1):97-105.
PMID: 33469490
Aim: To analyze the risk factors, ophthalmological features, treatment modalities and their effect on the visual outcome in patients with endogenous fungal endophthalmitis (EFE). Methods: Data retrieved from the medical...
7.
Ross M, Ofri R, Aizenberg I, Abu-Siam M, Peer O, Arad D, et al.
Sci Rep
. 2020 Nov;
10(1):19314.
PMID: 33168939
Achromatopsia is an inherited retinal disease characterized by loss of cone photoreceptor function. Day blind CNGA3 mutant Improved Awassi sheep provide a large animal model for achromatopsia. This study measured...
8.
Tiosano L, Ayalon A, Banin E, Averbukh E, Jaouni T, Chowers I
Curr Eye Res
. 2020 Aug;
46(4):539-545.
PMID: 32804540
Purpose: To evaluate the anatomical correlation between fellow eyes for bilateral second-line anti-VEGF treatment in eyes with bilateral diabetic macular edema (DME) with incomplete response to first-line bevacizumab therapy. Methods:...
9.
Ross M, Obolensky A, Averbukh E, Ezra-Elia R, Yamin E, Honig H, et al.
Hum Gene Ther
. 2020 Jun;
31(13-14):719-729.
PMID: 32486858
Gene augmentation therapy based on subretinal delivery of adeno-associated viral (AAV) vectors is proving to be highly efficient in treating several inherited retinal degenerations. However, due to potential complications and...
10.
Levinger N, Beykin G, Grunin M, Almeida D, Levy J, Levine H, et al.
Eur J Ophthalmol
. 2020 May;
31(3):1094-1100.
PMID: 32363931
Purpose: Visual outcome in patients with neovascular age-related macular degeneration is variable. We aimed to evaluate for association between socioeconomic status visual acuity in neovascular age-related macular degeneration. Methods: A...